ICGs, particularly the key members such as CTLA-4 and PD-1, are profoundly involved in immune tolerance and proliferation of glioma cells, and their blockage might inhibit the progression of gliomas (Ghouzlani et al., 2021). Here, CTLA4 is linked to glioma.